Selecta Biosciences Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.52 |
Market Cap |
$77.93 M |
Shares Outstanding |
44.79 M |
Public Float |
33.64 M |
Address |
480 Arsenal Way Watertown Massachusetts 02472 United States |
Employees | - |
Website | http://www.selectabio.com |
Updated | 07/08/2019 |
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The firm produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. Its proprietary pipeline includes SVP-enabled enzyme, oncology, and gene therapies. |